PHR Q1 2026 Earnings EPS Falls Short by 59 Stock Edges Higher Ramaco Resources METC Q1 2026 Earnings EPS Misses Estimates by 4045 While Stock Gains Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses Wendys Q1 2026 Earnings EPS Beats Estimates by 241 as Stock Gains CPT Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency MMM Q1 2026 Earnings Earnings Beat Estimates on Cost Discipline and Operational Efficiency